The IXORA trial is a head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis. Watch the video to find out the summary of the IXORA trial results!
IXORA trial: Comparison Between Ixekizumab and Guselkumab for Plaque Psoriasis
Sian Lin
This writer is part of the Medical Channel Asia editorial team. The Medical Channel Asia editorial team brings together a diverse group of seasoned journalists, pharmacists, and doctor to deliver breaking news, insightful analysis, informed opinions, and thought-provoking perspectives into the world of healthcare.
Related Posts
